Should azithromycin 1g be abandoned as a treatment for bacterial STIs? the case for and against

Sexually Transmitted Infections

Volumn 93, Issue 2, 2017, Pages 85-87

  Horner, Patrick ^a   Saunders, John ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

ANTIBIOTICS; ANTIMICROBIAL RESISTANCE; AZITHROMYCIN; BACTERIAL INFECTION

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; HUMAN; META ANALYSIS (TOPIC); MONOTHERAPY; NONHUMAN; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; WORLD HEALTH ORGANIZATION; BACTERIUM; BLOOD; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; NEISSERIA GONORRHOEAE;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 84978886284     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2015-052414     Document Type: Review

References (36)

1. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993;31(Suppl E):39-50.
2. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011;24:498-514.
3. Handsfield HH, Stamm WE. Treating chlamydial infection: compliance versus cost. Sex Transm Dis 1998;25:12-13.
4. Organisation WH. Guidelines for the management of sexually transmitted infections. 2004. http://www. who. int/hiv/pub/sti/pub6/en/
5. Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections-can we hit a moving target BMC Infect Dis 2015;15:343.
6. Horner PJ. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Infect 2012;88:154-6.
7. Jensen JS, Bradshaw CS, Tabrizi SN, et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008;47:1546-53.
8. Gillespie SH. Evolution of drug resistance in mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 2002;46:267-74.
9. Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015;15:364.
10. Lu H, Li K, Gong W, et al. High frequency of the 23S rRNA A2058G mutation of Treponema pallidum in Shanghai is associated with a current strategy for the treatment of syphilis. Emerg Microbes Infect 2015;4:e10.
11. Kong FY, Tabrizi SN, Fairley CK, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: A systematic review and meta-analysis. J Antimicrob Chemother 2015;70:1290-7.
12. van Liere GA, Dirks JA, Hoebe CJ, et al. Anorectal chlamydia trachomatis load is similar in men who have sex with men and women reporting anal sex. PLoS ONE 2015;10:e0134991.
13. Gratrix J, Singh AE, Bergman J, et al. Evidence for increased chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis 2015;60:398-404.
14. Ding A, Challenor R. Rectal Chlamydia in heterosexual women: more questions than answers. Int J STD AIDS 2014;25:587-92.
15. Hosenfeld CBM, Workowski KAM, Berman SM, et al. Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sex Transm Dis 2009;36:478-89.
16. Horner P, Blee K, Adams E. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 gram! Curr Opin Infect Dis 2014;27:68-74.
17. Horner P, Ingle S, Garrett F, et al. P09. 03 Treatment of mycoplasma genitalium with azithromycin 1 g is less efficacious and associated with induction of macrolide resistance compared to a 5-day regimen. Sex Transm Infect 2015;91(Suppl 2):A148.
18. Lau A, Bradshaw CS, Lewis D, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: A systematic review and meta-analysis. Clin Infect Dis 2015;61:1389-99.
19. Kong FY, Tabrizi SN, Law M, et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 2014;59:193-205.
20. Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015;60:1228-36.
21. Stamm LV. Syphilis: Antibiotic treatment and resistance. Epidemiol Infect 2015;143:1567-74.
22. Bignell C, Garley J. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Sex Transm Infect 2010;86:422-6.
23. Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS 2016;27:251-67.
24. Unemo M, Endre KM, Moi H. Five-day azithromycin treatment regimen for mycoplasma genitalium infection also effectively eradicates chlamydia trachomatis. Acta Derm Venereol 2015;95:730-2.
25. Public Health England. National chlamydia screening programme standards. 7th edn. 2014. https://www. gov. uk/government/publications/ncsp-standards ( publisher PHE)
26. Ljubin-Sternak S, Mestrovic T, Vilibic-Cavlek T, et al. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate. Folia Microbiol (Praha) 2013;58:361-5.
27. West SK, Moncada J, Munoz B, et al. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control J Infect Dis 2014;210:65-71.
28. Dugan J, Andersen AA, Rockey DD. Functional characterization of IScs605, an insertion element carried by tetracycline-resistant Chlamydia suis. Microbiology (Reading, Engl) 2007;153(Pt 1):71-9.
29. Review on Antimicrobial Resistance. Rapid Diagnostics: Stopping unnecessary use of antibiotics. 2015. http://amr-review. org/sites/default/files/Rapid% 20Diagnostics%20-%20Stopping%20Unnecessary%20use%20of%20Antibiotics. pdf
30. Nigro G, Mazzocco M, Mattia E, et al. Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2011;24:983-9.
31. Silva MJ, Florêncio GL, Gabiatti JR, et al. Perinatal morbidity and mortality associated with chlamydial infection: A meta-analysis study. Braz J Infect Dis 2011;15:533-9.
32. Kakar S, Bhalla P, Maria A, et al. Chlamydia trachomatis causing neonatal conjunctivitis in a tertiary care center. Indian J Med Microbiol 2010;28:45-7.
33. Adair CD, Gunter M, Stovall TG, et al. Chlamydia in pregnancy: A randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998;91:165-8.
34. Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 2000;(2):CD000054.
35. Ong JJ, Chen M, Hocking J, et al. Chlamydia screening for pregnant women aged 16-25 years attending an antenatal service: A cost-effectiveness study. BJOG 2016;123:1194-202.
36. Adams EJ, Charlett A, Edmunds WJ, et al. Chlamydia trachomatis in the United Kingdom: A systematic review and analysis of prevalence studies. Sex Transm Infect 2004;80:354-62.